BRIEF-FDA approves new indication for Ipsen's somatuline depot injection
September 18, 2017 at 08:26 AM EDT
* U.S. FDA approves new indication for Ipsen's somatuline® depot (lanreotide) injection for the treatment of carcinoid syndrome Source text for Eikon: Further company coverage:
